Pulmonary Embolism Flashcards
What is Pulmonary Embolism
Blockage of pulmonary arteries by thrombus, fat or air embolus, or tumor tissue
Obstructs alveolar perfusion
Most commonly affects lower lobes
Risk Factors
Deep vein thrombosis (90%)
Immobility or reduced mobility
Surgery
History of DVT
Malignancy
Obesity
Oral contraceptives/ hormones-
Secondary to estrogen and progesterone increasing clotting factors
Smoking
Heart failure
Pregnancy/delivery
Clotting disorders
Atrial fibrillation
Central venous catheters
Fractured long bones
Clinical Manifestations
Variable
Dyspnea most common
Tachypnea, cough, chest pain, hemoptysis, crackles, wheezing, fever, tachycardia, syncope, change in LOC
Dependent on size and extent of emboli
Clinical Manifestations
Pulmonary infarction
Alveolar necrosis and hemorrhage
Abscess
Pleural effusion
Pulmonary hypertension
Results from hypoxemia associated with massive or recurrent emboli
Right ventricular hypertrophy
Diagnostic Studies
Arterial blood gases
Chest x-ray
Electrocardiogram
Troponin levels
B-type natriuretic peptide
D-Dimer
- Elevated with any clot degradation
- False negatives with small PE
Spiral (helical) CT scan
- Most frequently used dx test
- Requires IV contrast media
Ventilation-perfusion (V/Q) scan
- Used if patient cannot have contrast
- Two components
- Perfusion scanning
- Ventilation scanning
Pulmonary angiography.
-Most sensitive but invasive
Arterial blood gases (ABGs)
Collaborative Care
Prevention—the key!
- Sequential compression devices
- Early ambulation
- Prophylactic anticoagulation
Goals of TX
Prevent further thrombi
Prevent further embolization to pulmonary system
Provide cardiopulmonary support
Supportive care variable
Oxygen → mechanical ventilation
Fluids, diuretics, analgesics
Drug Therapy
Anticoagulation
- Low-molecular-weight heparin (LHWH)
- Unfractionated IV heparin- aPPT level-Prevents clots –dissolve them
Warfarin (Coumadin)-PT/INR
Fibrinolytic agents
- Tissue plasminogen activator (tPA)
- Alteplase (Activase)
Surgical Therapy
Pulmonary embolectomy for massive PE
Inferior vena cava (IVC) filter
- Prevents migration of clots in pulmonary system
Nursing Management
Semi-Fowler’s position
IV access
Oxygen therapy
Frequent assessments
Monitor laboratory results.
Emotional support and reassurance
May have to give bot hydration and diuretics if a CHF patient
Patient Teaching
Regarding long-term anticoagulant therapy
Measures to prevent DVT
Importance of follow-up exams
Evaluation
•Expected Outcomes
Adequate tissue perfusion and respiratory function
Adequate cardiac output
Increased level of comfort
No recurrence of PE